
Amydis Diagnostics Inc.
Detecting Ocular Biomarkers for Diseases of the Brain, Eye, and Heart
San Diego, United States · Founded 2015 · $4.9M raised
- Headquarters
- San Diego, California
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- amydis.com
- Total Funding
- $4.9M
- Last Round
- $3.4M GrantNov 2023
About
Amydis is a diagnostics company developing a new class of ocular tracers that enable digital detection and monitoring of disease-related molecular biomarkers through standard ocular imaging cameras. The technology targets neurodegenerative diseases including Alzheimer's, Parkinson's, and ALS by detecting biomarkers such as amyloid beta and TDP-43 through non-invasive eye exams. Amydis aims to accelerate diagnosis and improve clinical testing of novel therapeutics.
Summary
Amydis Diagnostics Inc. is a Biotech company based in San Diego, United States, founded in 2015. It has raised $4.9M in total, most recently a $3.4M Grant round in Nov 2023.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company

Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...